Skip to main content
Caplight Logo









MycRx

MycRx

Private
Austin, TexasHealthcare & Life Scienceshttps://mycrxpharma.com/

Last Round

VC Round

Nov 1, 2021

Total Funding Raised

$900,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

MycRx is a biotechnology company developing oral, small molecule inhibitors that target the Myc oncoprotein for the treatment of various cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

small-molecule inhibitorsoncologydrug discoveryMYC oncogenetargeted therapyundruggable targetspreclinical developmentbiotechnologydrug candidatesprecision medicinecancer therapeuticsbiotech startupIND-enabling studiesmolecular biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MycRx Comparables

Compare MycRx with similar companies based on industry and business-model similarity.

MycRx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
WebenPharma
87%
Incurix
81%
Peptomyc
78%

MycRx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 1, 2021

Key People

Founding team and executive leadership

Nick Glover

CEO

Executive Team

MycRx Investors

Notable investors and investment history

MycRx investors
InvestorRounds
Santé VenturesVC Round
MTPConnectGrant
Brandon CapitalVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 61% MoM.

  • Nov 1, 2021

    Funding round included Brandon Capital and Santé Ventures.

MycRx Filings

Explore SEC and related filing metadata, where available.

MycRx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MycRx's valuation, stock price, and market status.

Is MycRx a public or private company?

MycRx is a private company.

What is the current stock price of MycRx?

MycRx is a private company with no public stock price. No recent secondary market data is available.

How much is MycRx worth (valuation)?

Valuation information for MycRx is not publicly available.

Can I buy MycRx stock?

MycRx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MycRx's last funding round?

MycRx's most recent funding round was VC Round on November 1, 2021.

Who are the main investors in MycRx?

Key investors in MycRx include Santé Ventures, MTPConnect, Brandon Capital.

Will MycRx IPO soon?

No public IPO plans have been announced for MycRx.

How can I track MycRx secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MycRx's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAustin, Texas
Employee Range12
Year Founded2013
Last FundingNov 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?